Search results for "Inflammatory bowel disease"


 
Results 1 - 10 of about 22 for "Inflammatory bowel disease".

Antidepressants may mitigate link between inflammatory bowel disease and depression | ACP Gastroenterology Monthly

Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.

Telemedicine app reduced gastroenterology visits for inflammatory bowel disease | ACP Gastroenterology Monthly

The trial, which was conducted at multiple sites in the Netherlands, randomly assigned outpatients ages 18 to 75 years with inflammatory bowel disease without an ileoanal or ileorectal pouch system to standard care or the telemedicine system.

Inflammatory bowel disease in childhood linked to increased cancer risk | ACP Gastroenterology Monthly

A study in Sweden matched 9,405 incident cases of childhood-onset inflammatory bowel disease with 92,870 comparators from the general population and followed participants through adulthood until a median age of 27 years.

Previous gastroenteritis may be associated with later risk for IBD | ACP Gastroenterology Monthly

In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.

Spotlight on IBD sequelae | ACP Gastroenterology Monthly

One recent study found a threefold increase in mortality among patients with childhood-onset inflammatory bowel disease (IBD) compared to individuals without the disease, while another found that patients with IBD have a higher risk of certain

October 27, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Online decision aid may help selection of biologics in IBD | ACP Gastroenterology Monthly

In a survey, 41.3% of respondents with inflammatory bowel disease (IBD) said treatment efficacy was the most important attribute for a biologic, and 53.9% preferred subcutaneous administration at home over IV administration in a clinic.

Spotlight on IBD and Parkinson's disease | ACP Gastroenterology Monthly

Recent research has found that patients with inflammatory bowel disease (IBD) may have increased risk of Parkinson's disease and that this risk may be modified by anti-tumor necrosis factor therapy.

July 28, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Depression may be associated with higher risk for aggressive IBD | ACP Gastroenterology Monthly

A prospective observational cohort study assessed the effects of baseline depression on inflammatory bowel disease (IBD) in patients from seven U.S. academic centers.

Result Page: Prev   1   2   3   Next